Literature DB >> 1315946

Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased sensitivity to quinolone antibiotics.

J W Tapsall1, T R Shultz, E A Phillips.   

Abstract

Forty three strains of Neisseria gonorrhoeae with decreased sensitivity to quinolone antibiotics were detected amongst 2141 Australian isolates of gonococci examined in the years 1984 to 1990. The strains examined belonged to 23 different auxotype/serovar classes, were generally more resistant to other antibiotics and, in the majority of cases, were isolated from travellers entering or returning to Australia from SE Asia. Quinolone-sensitive wild-type gonococci became less sensitive to these agents in vitro at a relatively high frequency when grown in the presence of quinolone concentrations at or around the MIC (Mean Inhibitory Concentration) of the antibiotic. Further increments in the levels of quinolone resistance of the already less-sensitive gonococci were also produced by this means, but high-level resistance to these agents was not observed. This suggests that mechanisms other than alterations in the DNA-gyrase of the organisms were responsible for the changes seen. Although spread of quinolone resistance in gonococci in Australia is unlikely to be rapid, if these antibiotics are used in therapy, treatment regimens with higher rather than lower dosages of quinolone antibiotics should be employed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315946     DOI: 10.3109/00313029209063616

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  10 in total

1.  Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.

Authors:  T R Shultz; J W Tapsall; P A White
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy.

Authors:  Michael Dan; Francesca Poch; Bracha Sheinberg
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis.

Authors:  Tiffany R Shultz; Peter A White; John W Tapsall
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

4.  Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure.

Authors:  C A Ison; P J Woodford; H Madders; E Claydon
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

5.  High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.

Authors:  M Tanaka; J Kumazawa; T Matsumoto; I Kobayashi
Journal:  Genitourin Med       Date:  1994-04

6.  Reduced uptake and accumulation of norfloxacin in resistant strains of Neisseria gonorrhoeae isolated in Japan.

Authors:  M Tanaka; H Fukuda; K Hirai; M Hosaka; T Matsumoto; J Kumazawa
Journal:  Genitourin Med       Date:  1994-08

7.  The incidence of gonorrhoea and the antibiotic sensitivity of gonococci in Australia, 1981-1991. The Australian Gonococcal Surveillance Programme.

Authors: 
Journal:  Genitourin Med       Date:  1993-10

8.  Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin.

Authors:  C J Carlyn; L J Doyle; C C Knapp; M D Ludwig; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

9.  Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan.

Authors:  M Tanaka; T Matsumoto; I Kobayashi; U Uchino; J Kumazawa
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

Review 10.  Fluoroquinolone resistance in Neisseria gonorrhoeae.

Authors:  J S Knapp; K K Fox; D L Trees; W L Whittington
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.